Pyrimidine derivatives
AssigneeMochida Pharmaceutical Co., Ltd.
InventorsKazutoshi Yanagibashi, Kiyoshi Mizuguchi, Shuhei Ohnishi, Kimihiro Murakami
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel 5-(.omega.-substituted amino-alkanoyl amino)pyrimidine derivatives, processes for producing the derivatives, and pharmaceutical compositions containing said derivatives. The compounds in the present invention have potent effects of inhibiting ACAT activity and lowering serum cholesterol. The compounds of the present invention are extremely useful for the treatment and/or prevention of arteriosclerosis or hyperlipidemia.
Claims10
A pyrimidine derivative represented by the formula (I) or a salt thereof:
- ##STR13## wherein R.sup.10 represents hydrogen atom, an alkyl group of straight or branched chain having 1 to 4 carbon atoms, NR.sup.6 R.sup.7, SR.sup.8 or OR.sup.8,
- R.sup.2 represents hydrogen atom, NR.sup.9 R.sup.10, SR.sup.11, OR.sup.11, an alkyl group of straight or branched chain having 1 to 6 carbon atoms, or a halogen atom,
- R.sup.3 represents hydrogen atom, NR.sup.12 R.sup.13, SR.sup.14, OR.sup.14, an alkyl group of straight or branched chain having 1 to 6 carbon atoms, or a halogen atom,
- R.sup.4 and R.sup.5 are identical or different and each represents a group selected from the group consisting of hydrogen atom, an alkyl group of straight or branched chain having 1 to 12 carbon atoms, a benzyl group, a cycloalkyl group having 3 to 10 carbon atoms and a phenyl group which may be substituted with 1 to 5 substituents that are selected from the group consisting of an alkyl group of straight or branched chain having 1 to 6 carbon atoms, an alkoxyl group of straight or branched chain having 1 to 4 carbon atoms, a halogen atom, a hydroxy group and an alkylenedioxy group having 1 or 2 carbon atoms;
- or
- R.sup.4 and R.sup.5, together with the nitrogen atom to which they are bonded, form a piperazine ring substituted with a phenyl group, or a tetrahydroquinoline ring,
- R.sup.6, R.sup.7 and R.sup.8 are identical or different and each represents a group selected from the group consisting of hydrogen atom, and an alkyl group of straight or branched chain having 1 to 4 carbon atoms,
- R.sup.9, R.sup.10, R.sup.11, R.sup.12, R.sup.13 and R.sup.14 are identical or different and each represents a group selected from the group consisting of hydrogen atom, a phenyl group, a benzyl group, and an alkyl group of straight or branched chain having 1 to 10 carbon atoms, or
- R.sup.9 and R.sup.10, or R.sup.12 and R.sup.13, together with the nitrogen atom to which they are bonded, each form a morpholine ring, or a piperazine ring which may be substituted with an alkyl group of straight or branched chain having 1 to 4 carbon atoms, and
- n represents an integer from 1 to 6, provided that when n is 1 and R.sup.1 is a methyl or NH.sub.2 group, then at least one of R.sup.2 and R.sup.3 is not a methyl or ethyl group;
- and when n is 2, both R.sup.2 and R.sup.3 are not simultaneously methyl groups.
The pyrimidine derivative or salt thereof as claimed in claim 11, wherein R.sup.2 represents NR.sup.9 R.sup.10 or an alkyl group of straight or branched chain having 1 to 6 carbon atoms, R.sup.3 represents SR.sup.14, OR.sup.14 or an alkyl group of straight or branched chain having 1 to 6 carbon atoms, R.sup.4 and R.sup.5 are identical or different and each represents a group selected from the group consisting of an alkyl group of straight or branched chain having 1 to 12 carbon atoms, a cycloalkyl group having 3 to 10 carbon atoms, a benzyl group and a phenyl group which may be substituted with 1 or 2 substituents that are selected from the group consisting of an alkyl group of straight or branched chain having 1 to 6 carbon atoms, an alkoxyl group of straight or branched chain having 1 to 4 carbon atoms, a halogen atom, a hydroxy group and an alkylenedioxy group having 1 to 2 carbon atoms;
- or R.sup.4 and R.sup.5, together with the nitrogen atom to which they are bonded, form a piperazine ring substituted with a phenyl group, or a tetrahydroquinoline ring.
The pyrimidine derivative or salt thereof as claimed in claim 11, wherein R.sup.1 represents NR.sup.6 R.sup.7, SR.sup.9 or OR.sup.8, R.sup.2 represents NR.sup.9 R.sup.10 or an alkyl group of straight or branched chain having 1 to 6 carbon atoms, R.sup.3 represents SR.sup.14, OR.sup.14 or an alkyl group of straight or branched chain having 1 to 6 carbon atoms, R.sup.4 and R.sup.5 are identical or different and each represents a group selected from the group consisting of an alkyl group of straight or branched chain having 1 to 12 carbon atoms, a cycloalkyl group having 3 to 10 carbon atoms, a benzyl group and a phenyl group which may be substituted with 1 or 2 substituents that are selected from the group consisting of an alkyl group of straight or branched chain having 1 to 6 carbon atoms, an alkoxyl group of straight or branched chain having 1 to 4 carbon atoms, a halogen atom, a hydroxy group and an alkylenedioxy group having 1 or 2 carbon atoms;
- or R.sup.4 and R.sup.5, together with the nitrogen atom to which they are bonded, form a piperazine ring substituted with a phenyl group, or a tetrahydroquinoline ring.
A pharmaceutical composition which comprises a pharmaceutically acceptable carrier and an effective amount of at least one pyrimidine derivative represented by the formula (I) or a salt thereof:
- ##STR14## wherein R.sup.1 represents hydrogen atom, an alkyl group of straight or branched chain having 1 to 4 carbon atoms, NR.sup.6 R.sup.7, SR.sup.8 or OR.sup.8,
- R.sup.2 represents hydrogen atom, NR.sup.9 R.sup.10, SR.sup.11, OR.sup.11, an alkyl group of straight or branched chain having 1 to 6 carbon atoms, or a halogen atom,
- R.sup.3 represents hydrogen atom, NR.sup.12 R.sup.13, SR.sup.14, OR.sup.14, an alkyl group of straight or branched chain having 1 to 6 carbon atoms, or a halogen atom,
- R.sup.4 and R.sup.5 are identical or different and each represents a group selected from the group consisting of hydrogen atom, an alkyl group of straight or branched chain having 1 to 12 carbon atoms, a benzyl group, a cycloalkyl group having 3 to 10 carbon atoms and a phenyl group which may be substituted with 1 to 5 substituents that are selected from the group consisting of an alkyl group of straight or branched chain having 1 to 6 carbon atoms, an alkoxyl group of straight or branched chain having 1 to 4 carbon atoms, a halogen atom, a hydroxy group and an alkylenedioxy group having 1 or 2 carbon atoms;
- or
- R.sup.4 and R.sup.5, together with the nitrogen atom to which they are bonded, form a piperazine ring substituted with a phenyl group, or a tetrahydroquinoline ring,
- R.sup.6, R.sup.7 and R.sup.8 are identical or different and each represents a group selected from the group consisting of hydrogen atom, and an alkyl group of straight or branched chain having 1 to 4 carbon atoms,
- R.sup.9, R.sup.10, R.sup.11, R.sup.12, R.sup.13 and R.sup.14 are identical or different and each represents a group selected from the group consisting of hydrogen atom, a phenyl group, a benzyl group, and an alkyl group of straight or branched chain having 1 to 10 carbon atoms, or
- R.sup.9 and R.sup.10, or R.sup.12 and R.sup.13, together with the nitrogen atom to which they are bonded, each form a morpholine ring, or a piperazine ring which may be substituted with an alkyl group of straight or branched chain having 1 to 4 carbon atoms, and
- n represents an integer from 1 to 6, provided that when n is 1 and R.sup.1 is a methyl or NH.sub.2 group, then at least one of R.sup.2 and R.sup.3 is not a methyl or ethyl group;
- and when n is 2, both R.sup.2 and R.sup.3 are not simultaneously methyl groups.
A pyrimidine derivative represented by the formula (I) or a salt thereof:
- ##STR15## wherein R.sup.1 represents hydrogen atom, an alkyl group of straight or branched chain having 1 to 4 carbon atoms, NR.sup.6 R.sup.7, SR.sup.8 or OR.sup.8,
- R.sup.2 represents hydrogen atom, NR.sup.9 R.sup.10, SR.sup.11, OR.sup.11, an alkyl group of straight or branched chain having 1 to 6 carbon atoms, or a halogen atom,
- R.sup.3 represents hydrogen atom, NR.sup.12 R.sup.13, SR.sup.14, OR.sup.14, an alkyl group of straight or branched chain having 1 to 6 carbon atoms, or a halogen atom,
- R.sup.4 and R.sup.5 are identical or different and each represents a group selected from the group consisting of hydrogen atom, an alkyl group of straight or branched chain having 1 to 12 carbon atoms, a benzyl group, a cycloalkyl group having 3 to 10 carbon atoms and a phenyl group which may be substituted with 1 to 5 substituents that are selected from the group consisting of an alkyl group of straight or branched chain having 1 to 6 carbon atoms, an alkoxyl group of straight or branched chain having 1 to 4 carbon atoms, a halogen atom, a hydroxy group and an alkylenedioxy group having 1 or 2 carbon atoms;
- or
- R.sup.4 and R.sup.5, together with the nitrogen atom to which they are bonded, form a piperazine ring substituted with a phenyl group, or a tetrahydroquinoline ring,
- R.sup.6, R.sup.7 and R.sup.8 are identical or different and each represents a group selected from the group consisting of hydrogen atom, and an alkyl group of straight or branched chain having 1 to 4 carbon atoms,
- R.sup.9 and R.sup.10, R.sup.11, R.sup.12, R.sup.13 and R.sup.14 are identical or different and each represents a group selected from the group consisting of hydrogen atom, a phenyl group, a benzyl group, and an alkyl group of straight or branched chain having 1 to 10 carbon atoms, or
- R.sup.9 and R.sup.10, or R.sup.12 and R.sup.13, together with the nitrogen atom to which they are bonded, each form a morpholine ring, or a piperazine ring which may be substituted with an alkyl group of straight or branched chain having 1 to 4 carbon atoms, and
- n represents an integer from 2 to 6, provided that when n is 2, both R.sup.2 and R.sup.3 are not simultaneously methyl groups.
A pharmaceutical composition which comprises a pharmaceutically acceptable carrier and an effective amount of at least one selected from a pyrimidine derivative represented by the formula (I) or a salt thereof:
- ##STR16## wherein R.sup.1 represents hydrogen atom, an alkyl group of straight or branched chain having 1 to 4 carbon atoms, NR.sup.6 R.sup.7, SR.sup.8 or OR.sup.8,
- R.sup.2 represents hydrogen atom, NR.sup.9 R.sup.10, SR.sup.14, OR.sup.14, an alkyl group of straight or branched chain having 1 to 6 carbon atoms, or a halogen atom,
- R.sup.3 represents hydrogen atoms, NR.sup.12 R.sup.13, SR.sup.14, OR.sup.14, an alkyl group of straight or branched chain having 1 to 6 carbon atoms, or a halogen atom,
- R.sup.4 and R.sup.5 are identical or different and each represents a group selected from the group consisting of hydrogen atom, an alkyl group of straight or branched chain having 1 to 12 carbon atoms, a benzyl group, a cycloalkyl group having 3 to 10 carbon atoms and a phenyl group which may be substituted with 1 to 5 substituents that are selected from the group consisting of an alkyl group of straight or branched chain having 1 to 6 carbon atoms, an alkoxyl group of straight or branched chain having 1 to 4 carbon atoms, a halogen atom, a hydroxy group and an alkylenedioxy group having 1 or 2 carbon atoms;
- or
- R.sup.4 and R.sup.5, together with the nitrogen atom to which they are bonded, form a piperazine ring substituted with a phenyl group, or a tetrahydroquinoline ring,
- R.sup.6, R.sup.7 and R.sup.8 are identical or different and each represents a group selected from the group consisting of hydrogen atom, and an alkyl group of straight or branched chain having 1 to 4 carbon atoms,
- R.sup.9, R.sup.10, R.sup.11, R.sup.12, R.sup.13 and R.sup.14 are identical or different and each represents a group selected from the group consisting of hydrogen atom, a phenyl group, a benzyl group, and an alkyl group of straight or branched chain having 1 to 10 carbon atoms, or
- R.sup.9 and R.sup.10, or R.sup.12 and R.sup.13, together with the nitrogen atom to which they are bonded, each form a morpholine ring, or a piperazine ring which may be substituted with an alkyl group of straight or branched chain having 1 to 4 carbon atoms, and
- n represents an integer from 2 to 6, provided that when n is 2, both R.sup.2 and R.sup.3 are not simultaneously methyl groups.
Dependencies are inferred from the claim text.